Company / Shares Outstanding
RIGEL PHARMACEUTICALS INC Shares Outstanding History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Shares Outstanding
17.7M
FY2025
5-year range
17.5M / 173.4M
FY2021-FY2025
Trend
+1.3%
vs FY2024
Sector context
#203 of 212
Health Care
What the data says
Among 212 Health Care companies, RIGEL PHARMACEUTICALS INC is in the top 4% for shares outstanding. Improved from 173398645.00 to 17710216.00 over the past 2 years.
Based on SEC 10-K filings.
17710216.00 in FY2025 with a 5-year CAGR of -36.2%.
Improved from 173398645.00 to 17710216.00 over the past 2 years.
Health Care sector context is included.
Shares Outstanding over time
Growth rates
- 3-Year CAGR
- -53.1%
- 5-Year CAGR
- -36.2%
- 10-Year CAGR
- -
Sector benchmark
Top 4% in Health CareTop 4% of 212This company 17.7M Sector average 306.0M
▼
-94.2% below sector average
Key checks
Key Insights
- In FY2025, shares outstanding increased 1.3% year-over-year.
- Ranks #203 out of 212 companies in the Health Care sector.
- Peak shares outstanding was recorded in FY2023.
- Lowest shares outstanding in the period was in FY2024.
Company context
Key Data Points
- Altman Z-Score 1.19 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Shares OutstandingValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | 17.7M | +1.3% |
| FY2024 | 17.5M | -89.9% |
| FY2023 | 173.4M | +1.0% |
| FY2022 | 171.6M | +1.3% |
| FY2021 | 169.3M | +0.8% |
| FY2020 | 168.0M | +0.5% |
| FY2019 | 167.2M | +13.9% |
| FY2018 | 146.8M | +16.2% |
| FY2017 | 126.3M | +33.8% |
| FY2016 | 94.4M | +6.7% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026